Sepsis Diagnostics Market Study including Growth Factors, Types and Application by regions from 2023 to 2030

 Sepsis Diagnostics Industry Overview

The global Sepsis Diagnostics Market size is expected to reach USD 1.4 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 9.6% over the forecast period. The high prevalence of sepsis, the introduction of technologically advanced diagnostic systems, and increasing government initiatives are expected to propel market growth over the forecast period. Sepsis is a bloodstream disease that occurs as a result of a response to pathogenic microorganisms present in the blood. Patients suffering from this disease experience severe inflammation, which leads to prolonged hospitalization.

According to the WHO, around 30 million people are estimated to be affected by this disease every year. The NCBI stated that the largest number of this condition have been observed in the youngest and oldest age groups. Thus, there is a rising need for the early diagnosis of this disease. The WHO reported that every year, 1.2 million children and 3 million newborns are affected by this disease across the world. This has further boosted the demand for its diagnostic tools for quick results and improved patient outcomes. Increasing regulatory approval and the introduction of technologically advanced diagnostic solutions for sepsis are expected to facilitate market growth over the forecast period.

In May 2018, T2 Biosystems, Inc., a U.S.-based emerging diagnostic solutions company, received the U.S. FDA approval for its T2Bacteria Panel, intended for the detection of specific sepsis-causing bacterial pathogens in human whole blood specimens. The COVID-19 pandemic affected the growth of diagnostics products for sepsis in a moderately positive way. The worldwide spread of Coronavirus and the arising instances of sepsis among COVID-19 patients are probably going to expand the interest for fast detection, speeding up the use of instruments, reagents, and assay kits for recognition of sepsis. Pandemic-induced lockdown and other restrictions made individuals delay going through wellbeing checkups, influencing the number of tests performed and reagent deals.

The pandemic has featured the risk upon elders, who are more defenseless to complications, including intense respiratory distress condition, typically because of pneumonia, which builds the risk of creating sepsis. This has created a need for the early detection of sepsis among patients with COVID-19. Symptoms of sepsis, such as multiorgan injuries, develop in around 2.0 to 5.0% of COVID-19 cases 8 to 10 days post-hospitalization, based on the estimates of the Global Sepsis Alliance. To manage this situation, the Biomedical Advanced Research and Development Authority, in May 2020, extended its partnership with Beckman Coulter for the development of a digital algorithm to detect sepsis in patients with COVID-19.

Sepsis Diagnostics Market Segmentation

Grand View Research has segmented the global sepsis diagnostics market based on product, technology, pathogen, testing type, end-user, method and region:

Based on the Product Insights, the market is segmented into Instruments, Blood Culture Media and Assay Kits & Reagents.

  • The blood culture media product segment dominated the global market in 2021 and accounted for the largest share of more than 45.5% of the total revenue. The segment is expected to maintain its lead over the forecast period.
  • The instruments segments are also reported to show a constant growth rate over the forecast period owing to the rising awareness among the general population about healthcare and the increasing rate of surgical procedures.

Based on the Technology Insights, the market is segmented into Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry and Others.

  • The microbiology technology segment dominated the global market and accounted for the largest share of more than 48.5% of the overall revenue. This can be attributed to the fact that microbiology technology allows accurate detection and identification of microorganisms for sepsis diagnosis through the application of culture media tests.
  • The molecular diagnostics segment is anticipated to expand at the fastest CAGR over the forecast period. Increasing adoption of molecular diagnostic technology due to its several advantages, such as high sensitivity, accuracy, and less turnaround time, over other technologies is anticipated to drive the segment.

Based on the Pathogen Insights, the market is segmented into Bacterial Sepsis, Fungal Sepsis, Viral Sepsis and Others.

  • The bacterial sepsis segment held the largest revenue share of 79.5% in 2021 and is anticipated to maintain its lead over the forecast period owing to the rise in cases of bacterial sepsis, the higher occurrence of hospital-transmitted infections, and the rising number of surgical procedures conducted.
  • The fungal sepsis segment, although having less revenue share, is expected to maintain a significant CAGR over the forecast period. One of the major drivers of the pathogen segment is the increasing availability and the introduction of a new and wide range of sepsis diagnosis devices for pathogen detection.

Based on the Testing Type Insights, the market is segmented into Laboratory Testing and POC Testing.

  • The laboratory testing type segment dominated the market in 2021 with a share of more than 85.00%. This is mainly due to the fact that lab testing has greater accuracy in comparison to POC testing while diagnosing sepsis.
  • Clinical laboratory testingprovides an in-depth analysis of the pathogen and its drug resistance profile. In addition, routine testing of lactate levels, which are nonspecific, however, a useful marker of sepsis, is effectively performed in laboratory settings.

Based on the Method Insights, the market is segmented into Automated Diagnostics and Conventional Diagnostics.

Based on the End-User Insights, the market is segmented into Hospitals & Clinics, Pathology & Reference Laboratories and Research Institutes and Others.

Sepsis Diagnostics Regional Outlook

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Key Companies Profile

The key players operating in the market are adopting inorganic growth strategies, such as mergers and partnerships, for the development of novel diagnostic solutions.

Some prominent players in the global Sepsis Diagnostics market include

  • bioMérieux SA
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific, Inc.
  • Hoffmann-La Roche AG
  • Danaher CorporationLuminex Corporation
  • Bruker Corporation
  • Amara Health Analytics
  • Wolters Kluwer N.V.
  • Cerner Corporation
  • Epic Systems Corp.
  • Mckesson Corp.
  • GE Healthcare
  • Koninklijke Philips N.V.

Order a free sample PDF of the Sepsis Diagnostics Market Intelligence Study, published by Grand View Research.

Comments

Post a Comment

Popular posts from this blog

Spinal Implants & Devices Market Forecast Analysis by Manufacturer, Types, Applications and Regions 2023 – 2030

  Spinal Implants & Devices Industry Overview The global  Spinal Implants & Devices Market  size is expected to reach USD 19.0 billion by 2030 and is expected to expand at a CAGR of 5.2% in the forecast period, from 2023 to 2030, according to a new report by Grand View Research, Inc. The growing number of vehicular accidents is leading to increasing new cases of spinal cord injuries (SCIs). Other causes of SCIs include falls, violence, acts of violence, sports and recreation injuries, and diseases. Vehicular or road accidents and falls account for the majority of SCI cases. Fall-induced SCI is common among people aged 65 years and above. Acts of violence such as gunshot wounds or knife wounds account for around 12% of SCI cases. Sports activities such as diving in shallow water and impact sports lead to nearly 10% of SCIs. Cancer, osteoporosis, arthritis, and inflammation of the spinal cord also cause SCI. Based on National Spinal Cord Injury Statistical Center da...
Read more

Latin America Pharmaceutical Contract Manufacturing & Research Services Market Overview, Cost Structure Analysis and Forecast to 2030

  Latin America Pharmaceutical Contract Manufacturing & Research Services Industry Overview The  Latin America Pharmaceutical Contract Manufacturing & Research Services Market  size is expected to reach USD 40.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 7.5% from 2022 to 2030. The low cost of drug registration in Latin American countries and the economic growth are the key factors contributing to progress in this region. Moreover, factors such as the growing demand for generics, rising investments in R&D, the growing geriatric population, and the increasing burden of chronic diseases are responsible for market growth. The outbreak of COVID-19 has boosted the market growth as companies have increased investments in R&D and manufacturing to develop vaccines and drugs against the COVID-19. During the coronavirus outburst, the supply chains of biopharmaceutical companies remained robust...
Read more

Europe Orthopedic Navigation Systems Market - Global Industry Insights, Trends and Growth Opportunity Analysis to 2030

  Europe Orthopedic Navigation Systems Industry Overview The  Europe Orthopedic Navigation Systems Market  size is expected to reach USD 2,504.4 million by 2030, according to a new report published by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.8% from 2023 to 2030. The rising number of target diseases especially in the geriatric population is responsible for the rapid growth of the market. According to the Executive Agency for Health and Consumers, one in ten people in the geriatric population in Europe is suffering from osteoarthritis. Minimal invasion and low post-operative complications associated with computer-assisted surgery are anticipated to drive regional market growth over the forecast period. Moreover, the introduction of technologically advanced products is expected to induce demand for  orthopedic navigation systems . For instance, Orthokey Italia developed a new version of KiRA system integrating it with the iPad to ...
Read more